Design and synthesis of dual BRD4/Src inhibitors for treatment of triple-negative breast cancer.
Wang Y, Huang A, Chen L, Sun F, Zhao M, Zhang M, Xie Y, Xu S, Li M, Hong L, Li G, Wang R.
Wang Y, et al. Among authors: li g, li m.
Eur J Med Chem. 2024 Jan 15;264:116009. doi: 10.1016/j.ejmech.2023.116009. Epub 2023 Nov 29.
Eur J Med Chem. 2024.
PMID: 38070430